En un contexto donde cada vez más personas buscan alternativas de salud integrales y basadas en la evidencia, ISEIH emerge como la institución de referencia en formación especializada. El interés por la medicina natural ha experimentado un crecimiento sostenido durante la …
Startups raised $14.2 billion last year, the highest funding total since 2022. Health AI companies collected 54% of total funding, according to Rock Health.
Digital health funding increases in 2025, spurred by AI: report Read More »
Merck CEO Rob Davis expressed high confidence during the company’s J.P. Morgan presentation on Monday, revealing that the company is open to deals in the range of “multi tens of billions of dollars.”
JPM26: Confident Merck Sees Growth Through Keytruda Loss of Exclusivity Read More »
The FDA previously rejected Zycubo for Menkes disease in October last year, citing issues with the drug’s manufacturing facility.
Sentynl, Fortress Bounce Back With FDA Approval for Rare Pediatric Disease Read More »
Johnson & Johnson’s second facility in Wilson, North Carolina, is part of a $55 billion push to make all advanced medicines used in the U.S. domestically.
J&J To Add 500 Jobs at New Plant, Doubling Down on North Carolina Read More »
Obesity took center stage on the first day of the 2026 J.P. Morgan Healthcare Conference, with industry frontrunners Eli Lilly and Novo Nordisk providing supply chain, regulatory and pricing updates.
JPM Day 1: Obesity Front-and-Center, Q4 Sales Beats Read More »
Facing the loss of exclusivity on key products, Pfizer has pulled forward its lead obesity asset into Phase III and targeted a 2028 launch. CEO Albert Bourla explained the pharma’s strategy at J.P. Morgan on Monday.
JPM26: Pfizer Fast-Tracks Obesity Programs in Race Against Patent Cliff Read More »
Jefferies analysts forecast a $1 billion market opportunity for each of Sarepta’s siRNA programs for facioscapulohumeral muscular dystrophy and myotonic dystrophy type 1.
After Mortality-Marred Year, Sarepta Looks Ahead to Catalyst-Rich 2026 Read More »
AbbVie has also pledged to participate in TrumpRx and offer many of its products, including Humira, on a direct-to-patient basis. In exchange, the pharma secured exemptions from tariffs and other future pricing directives.
AbbVie Commits $100B in US R&D, Manufacturing, Winning Tariff, Pricing Exemptions Read More »
Un estudio reciente demuestra que el precúneo, una región estratégica del cerebro encargada de la consciencia de uno mismo, la percepción corporal, la memoria autobiográfica y la construcción de la identidad alcanza sus proporciones y forma casi definitivas …
